HPV and cofactors for invasive cervical cancer in Morocco: A multicentre case-control study

BMC Cancer

Volumn 17, Issue 1, 2017, Pages

  Berraho, Mohamed ^a   Amarti Riffi, Afaf ^b   El Mzibri, Mohammed ^c   Bezad, Rachid ^d,e   Benjaafar, Noureddine ^f   Benideer, Abdelatif ^g   Matar, Noureddine ^g   Qmichou, Zinab ^c,h   Abda, Naima ^a   Attaleb, Mohammed ^c   Znati, Kaoutar ^b   El Fatemi, Hind ^b   Bendahhou, Karima ⁱ   Obtel, Majdouline ^j   Filali Adib, Abdelhai ^d   Mathoulin Pelissier, Simone ^k,l   Nejjari, Chakib ^a  

^a SIDI MOHAMED BEN ABDELLAH UNIVERSITY   (Morocco)

^b HASSAN II UNIVERSITY HOSPITAL   (Morocco)

^c CENTRE NATIONAL DE L ENERGIE DES SCIENCES TECHNIQUES NUCLEAIRES   (Morocco)

^d IBN SINA HOSPITAL   (Morocco)

^e MOHAMMED V UNIVERSITY   (Morocco)

^f NATIONAL INSTITUTE OF ONCOLOGY   (Morocco)

^g IBN ROCHD UNIVERSITY HOSPITAL   (Morocco)

^h HASSAN II UNIVERSITY OF CASABLANCA   (Morocco)

ⁱ Cancer Registry of Casablanca   (Morocco)

^j Ministry of Health Morocco   (Morocco)

^k UNIVERSITÉ DE BORDEAUX   (France)

^l Centre of Clinical Investigation Clinical Epidemiology   (France)

more..

Author keywords

Case control study; Cervical cancer; Determinants; Hpv; Morocco

Indexed keywords

ADULT; ARTICLE; CASE CONTROL STUDY; CONCURRENT SEXUAL PARTNERSHIP; CONTRACEPTION; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MEDICAL HISTORY; MENSTRUATION; MOROCCO; NONHUMAN; PAPILLOMAVIRUS INFECTION; PARITY; RISK FACTOR; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUALLY TRANSMITTED DISEASE; UTERINE CERVIX CANCER; WART VIRUS; AGED; HUMAN PAPILLOMAVIRUS TYPE 16; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOGENICITY; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR; VIROLOGY;

VIRUS DNA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MOROCCO; PAPILLOMAVIRUS INFECTIONS; RISK FACTORS; SEXUALLY TRANSMITTED DISEASES; UTERINE CERVICAL NEOPLASMS;

EID: 85021088632     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/s12885-017-3425-z     Document Type: Article

References (35)

1. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, et al. Worldwide burden of cervical cancer in 2008. Ann Oncol. 2011;22:2675-86.
2. Ferlay J, Shin H, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
3. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human HPV is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-9.
4. Association Lalla Salma de lutte contre le Cancer 2012. Registre des cancers du grand Casablanca 2005-2007. http://www.contrelecancer.ma/documents/registre-des-cancers-de-la-region-du-grand-casab-2/. Accessed 10 Sept 2012.
5. Bennani B, Bennis S, Nejjari C, Ouafik L, Melhouf MA, El Rhazi K, et al. Correlates of HPV: a cross-sectional study in women with normal cytology in north-central Morocco. J Infect Dev Ctries. 2012;6:543-50.
6. Lalaoui K, El Mzibri M, Amrani M, Belabbas MA, Lazo PA. Human papillomavirus DNA in cervical lesions from Morocco and its implications for cancer control. Clin Microbiol Infect. 2003;9:144-8.
7. El Hamdani W, Amrani M, Attaleb M, Laantri N, Ennaji MM, Khyatti M, et al. EGFR, p16INK4a and E-cadherin immuno-histochemistry and EGFR point mutations analyses in invasive cervical cancer specimens from Moroccan women. Cell Mol Biol (Noisy-le-grand). 2010;56(Suppl):OL1373-84.
8. El Khair MM, Ennaji MM, El Kebbaj R, Mhand RA, Attaleb M, El Mzibri M. p53 codon 72 polymorphism and risk of cervical carcinoma in Moroccan women. Med Oncol. 2010;27:861-6.
9. Chaouki N, Bosch FX, Muñoz N, Meijer CJ, El Gueddari B, El Hazi A, et al. The viral origin of cervical cancer in Rabat, Morocco. Int J Cancer. 1998;75:546-54.
10. Asato T, Maehama T, Nagai Y, Kanazawa K, Uezato H, Kariya K. A. Large case-control study of cervical cancer risk associated with human papillomavirus infection in Japan, by nucleotide sequencing-based genotyping. J Infect Dis. 2004;189:1829-32.
11. Lee SH, Vigliotti VS, Vigliotti JS, Pappu S. Routine human papillomavirus genotyping by DNA sequencing in community hospital laboratories. Infect Agent Cancer. 2007;2:11.
12. Muñoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, et al., International Agency for Research on Cancer multicenter cervical cancer study group. Epidemiologic classification of human HPV types associated with cervical cancer. N Engl J Med. 2003;348:518-27.
13. Clifford GM, Smith JS, Plummer M, Muñoz N, Franceschi S. Human HPV types in invasive cervical cancer worldwide: a metaanalysis. Br J Cancer. 2003;88:63-7.
14. Odida M, Sandin S, Mirembe F, Kleter B, Quint W, Weiderpass E. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infect Agent Cancer. 2011;25:6-8.
15. Castellsagué X, Díaz M, de Sanjosé S, Muñoz N, Herrero R, Franceschi S, et al. International agency for research on cancer multicenter cervical cancer study group. Worldwide human HPV etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 2006;98:303-15.
16. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006;24Suppl 3:S3/1-10.
17. de Sanjose S, Almirall R, Lloveras B, Font R, Diaz M, Muñoz N, et al. Cervical human HPV infection in the female population in Barcelona. Spain SexTransmDis. 2003;30:788-93.
18. Thomas JO, Herrero R, Omigbodun AA, Ojemakinde K, Ajayi IO, Fawole A, et al. Prevalence of HPV infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer. 2004;90:638-45.
19. Molano M, Posso H, Weiderpass E, van den Brule AJ, Ronderos M, Franceschi S, et al. Prevalence and determinants of HPV infection among Colombian women with normal cytology. Br J Cancer. 2002;87:324-33.
20. Clifford GM, Gallus S, Herrero R, Muñoz N, Snijders PJ, Vaccarella S, et al., IARC HPV Prevalence Surveys Study Group. Worldwide distribution of human HPV types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis. Lancet. 2005;366:991-8.
21. Castle PE, Walker JL, Schiffman M, Wheeler CM, ALTS Group. Hormonal contraceptive use, pregnancy and parity, and the risk of cervical intraepithelial neoplasia 3 among oncogenic HPV DNA-positive women with equivocal or mildly ab normal cytology. Int J Cancer. 2005;117:1007-12.
22. Cartwright RA, Sinson JD. Carcinoma of penis and cervix. Lancet. 1980;1:97.
23. Hellberg D, Nilsson S. Genital cancer among wives of men with penile cancer. A study between 1958 and 1982. Br J Obstet Gynaecol. 1989;96(2):221-5.
24. Smith PG, Kinlen LJ, Gc W, Adelstein AM. Fox AJ. Mortality of wives of men dying with cancer of the penis. Br J Cancer. 1980;41:422-8.
25. Il K. Venereal factors in human cervical cancer: evidence from marital clusters. Cancer. 1977;39:1912-9.
26. Brinton LA, Fraumeni JF Jr. Epidemiology of uterine cervical cancer. J Chronic Dis. 1986;39:1051-65.
27. Parikh S, Brennan P, Boffetta P. Meta-analysis of social inequality and the risk of cervical cancer. Int J Cancer. 2003;105:687-91.
28. Hildesheim A, Gravitt P, Schiffman MH, Kurman RJ, Barnes W, Jones S, et al. Determinants of genital human HPV infection in low-income women in Washington, D.C. Sex Transm Dis. 1993;20:279-85.
29. Stone KM, Karem KL, Sternberg MR, McQuillan GM, Poon AD, Unger ER, et al. Seroprevalence of human HPV type 16 infection in the United States. J Infect Dis. 2002;186:1396-402.
30. Peng H, Liu S, Mann V, Rohan T, Rawls W. Human HPV types 16 and 33, herpes simplex type 2 and other risk factors for cervical cancer in Sichuan Province, China. Int J Cancer. 1991;47:711-6.
31. Smith JS, Muñoz N, Franceschi S, Eluf-Neto J, Herrero R, Peeling RW. Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA. 2001;285:1704.
32. Smith JS, Bosetti C, Muñoz N, Herrero R, Bosch FX, Eluf-Neto J. Chlamydia trachomatis and invasive cervical cancer: a pooled analysis of the IARC multicentric case-control study. Int J Cancer. 2004;111:431-9.
33. Association Lalla Salma de lutte contre le Cancer 2009. Rapport Volumes 3: Etude des stades de diagnostic et des résultats des traitements des cancers au Maroc.
34. Kleinbaum DG. Logistic regression: a self- learning text. Springer-Verlag 1994. ISBN 978-1-4419-1742-3. http://www.springer.com/us/book/9781441917416.
35. Haut-Commissariat au Plan 2008. National survey on income and living standards of households 2006/2007.